BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development-stage company focused on non invasive blood glucose monitoring in the acute care environment, today unveiled design and performance enhancements to the company’s first product, the SENTRIS-100™ glucose monitor. The enhancements to SENTRIS-100™ include changes in both design and functionality.
